Hearts of Athletes

Duke University

Status: Terminated

Conditions: Cardiac Involvement With COVID-19

Study type: Observational

Funder types: Other

Identifiers

NCT04736004

Pro00106943

Details and patient eligibility

About

The Hearts of Athletes study is being conducted to determine the heart involvement with COVID-19 in athletes. This study aims to enroll any Adult (18 years of age or greater)

• Athlete is defined as NCAA Collegiate Athlete, Professional Athlete, Military, or Olympic Athlete will be eligible for the study.

With COVID-19

• COVID-19 diagnosed via an RT-PCR (nasal or throat swab test) prior to enrollment

Or without COVID-19

• Identified as a local Control participant (similar sport) to a participant with COVID-19, who is willing to undergo a standard cardiovascular evaluation

Participants with and without COVID-19 will use their mobile devices to provide health information, like symptoms, by answering survey questions daily for 30 days. Also, participants will allow their de-identified cardiac images to be sent to the Duke Heart Center for blinded analysis.

No physical risks are associated with this study. One possible risk, although minimal, is loss of confidentiality.

Enrollment: 1 patient

Sex: All

Ages: 18 to 30 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Any adult athlete (defined as NCAA Collegiate Athlete, Professional Athlete, or Olympic Athlete) will be eligible for the study.
• COVID-19 diagnosed via an RT-PCR, or history of COVID-19 antibodies at least 10 days and less than 6 months prior to consent
• No longer requiring quarantine per local health recommendations, prior to cardiovascular evaluation.
• Identification as a Control participant (similar sport) to a participant without COVID-19 willing to undergo cardiovascular evaluation

Exclusion criteria

• Anyone with known cardiovascular disease - defined as known myocardial disease, valvular heart disease, or known coronary heart disease
• Anyone without the ability to provide informed consent
• Anyone with a known contraindication to cardiac magnetic resonance (metallic implant)

Trial design

1 participants in 2 patient groups

Athletes with COVID-19

Athletes without COVID-19 (control)